NTB stock news
This page provides real-time market news, earnings updates, and company announcements related to New Tymbal Resources Ltd (NTB).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-22 12:47 EST
DOJ Investigates Netflix’s Influence on Filmmakers During Warner Merger Review
101 finance2026-02-22 13:00:19
DoorDash Rebound Signal: Analysts See Double-Digit Upside From Here
Finviz2026-02-22 13:30:38
Consumer Tech News (Feb 16-20): Big Techs To Boost AI in India, EV Policy Shifts & More
Finviz2026-02-22 13:33:10
Here's Walmart's hidden $1 trillion strategy
101 finance2026-02-22 13:33:17
Payoneer (PAYO) Strikes Strategic Partnership With Bridge
Finviz2026-02-22 14:39:38
BWS Reiterates Buy on Nebius Group (NBIS) With $130 Target
Finviz2026-02-22 15:27:38
Rocket Lab (RKLB) Launches Cassowary Vex Hypersonic Mission for the U.S. Department of War
Finviz2026-02-22 15:27:38
Mixed Analyst Sentiment on Tesla (TSLA) Post 5 New Collisions in the "Robotaxi" Fleet
Finviz2026-02-22 15:27:39
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Finviz2026-02-22 15:33:41
Goldman’s board ends DEI — and that might not be such a bad thing
101 finance2026-02-22 15:40:06
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
Finviz2026-02-22 16:03:14
‘Funds are shifting away from technology’: Wall Street considers which stocks will benefit as AI-driven market fears grow
101 finance2026-02-22 16:03:37
Biotechnology company MoonLake Immunotherapeutics announced that its innovative drug Sonelokimab achieved positive topline results in a Phase II clinical trial for axial spondyloarthritis.
老虎证券2026-02-22 16:06:48
Billionaire Stanley Druckenmiller Pours $290,836,000 Into Two Assets, Exits Exposure To Three Major US Banks
Dailyhodl2026-02-22 16:09:20
nVent Postpones Investor Day due to Weather-related State of Emergency Declared in New York City Metropolitan Area
Finviz2026-02-22 16:09:52
MongoDB, Inc. (MDB) Seen as GenAI Database Leader Ahead of Earnings, RBC Reiterates Outperform
Finviz2026-02-22 16:54:12
Datadog, Inc. (DDOG) Reaffirmed as Top Pick After Investor Day Highlights AI and ARR Expansion
Finviz2026-02-22 16:54:12
Hedge Funds Are Buying Power From Caterpillar, (CAT) Says Jim Cramer
Finviz2026-02-22 17:06:44
Jim Cramer Believes Meta's (META) Developing Its Own Cloud Business
Finviz2026-02-22 17:06:43
NVIDIA's (NVDA) Cost of Ownership is Lower Than What People Think, Says Jim Cramer
Finviz2026-02-22 17:09:09
Atlassian Corporation (TEAM) Appoints James Chuong as its CFO
Finviz2026-02-22 17:12:45
IREN Limited (IREN) Appoints John Gross as Chief Innovation Officer
Finviz2026-02-22 17:12:45
Citi Notes Snowflake's (SNOW) 30% Pull Back to Be an Overreaction
Finviz2026-02-22 17:12:46
TechCrunch Mobility: Waymo presents its case
101 finance2026-02-22 17:24:16
Payoneer (PAYO) Strikes Strategic Partnership With Bridge
Finviz2026-02-22 14:39:38
BWS Reiterates Buy on Nebius Group (NBIS) With $130 Target
Finviz2026-02-22 15:27:38
Rocket Lab (RKLB) Launches Cassowary Vex Hypersonic Mission for the U.S. Department of War
Finviz2026-02-22 15:27:38
Mixed Analyst Sentiment on Tesla (TSLA) Post 5 New Collisions in the "Robotaxi" Fleet
Finviz2026-02-22 15:27:39
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Finviz2026-02-22 15:33:41
Goldman’s board ends DEI — and that might not be such a bad thing
101 finance2026-02-22 15:40:06
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
Finviz2026-02-22 16:03:14
‘Funds are shifting away from technology’: Wall Street considers which stocks will benefit as AI-driven market fears grow
101 finance2026-02-22 16:03:37
Biotechnology company MoonLake Immunotherapeutics announced that its innovative drug Sonelokimab achieved positive topline results in a Phase II clinical trial for axial spondyloarthritis.
老虎证券2026-02-22 16:06:48
Billionaire Stanley Druckenmiller Pours $290,836,000 Into Two Assets, Exits Exposure To Three Major US Banks
Dailyhodl2026-02-22 16:09:20
nVent Postpones Investor Day due to Weather-related State of Emergency Declared in New York City Metropolitan Area
Finviz2026-02-22 16:09:52
MongoDB, Inc. (MDB) Seen as GenAI Database Leader Ahead of Earnings, RBC Reiterates Outperform
Finviz2026-02-22 16:54:12
Datadog, Inc. (DDOG) Reaffirmed as Top Pick After Investor Day Highlights AI and ARR Expansion
Finviz2026-02-22 16:54:12
Hedge Funds Are Buying Power From Caterpillar, (CAT) Says Jim Cramer
Finviz2026-02-22 17:06:44
Jim Cramer Believes Meta's (META) Developing Its Own Cloud Business
Finviz2026-02-22 17:06:43
NVIDIA's (NVDA) Cost of Ownership is Lower Than What People Think, Says Jim Cramer
Finviz2026-02-22 17:09:09
Atlassian Corporation (TEAM) Appoints James Chuong as its CFO
Finviz2026-02-22 17:12:45
IREN Limited (IREN) Appoints John Gross as Chief Innovation Officer
Finviz2026-02-22 17:12:45
Citi Notes Snowflake's (SNOW) 30% Pull Back to Be an Overreaction
Finviz2026-02-22 17:12:46
TechCrunch Mobility: Waymo presents its case
101 finance2026-02-22 17:24:16
NTB stock chart
NTB stock detailsNTB stock price change
On the last trading day, NTB stock closed at 0.04 CAD, with a price change of 12.50% for the day.
Trade stock futuresAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more